File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1073/pnas.1711169114
- Scopus: eid_2-s2.0-85029551622
- PMID: 28874568
- WOS: WOS:000411157100071
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Proteoliposome-based full-length ZnT8 self-antigen for type 1 diabetes diagnosis on a plasmonic platform
Title | Proteoliposome-based full-length ZnT8 self-antigen for type 1 diabetes diagnosis on a plasmonic platform |
---|---|
Authors | |
Keywords | Autoantibody Full-length ZnT8 Plasmonic Proteoliposome Type 1 diabetes |
Issue Date | 2017 |
Citation | Proceedings of the National Academy of Sciences of the United States of America, 2017, v. 114, n. 38, p. 10196-10201 How to Cite? |
Abstract | Identified as a major biomarker for type 1 diabetes (T1D) diagnosis, zinc transporter 8 autoantibody (ZnT8A) has shown promise for staging disease risk and disease diagnosis. However, existing assays for ZnT8 autoantibody (ZnT8A) are limited to detection by soluble domains of ZnT8, owing to difficulties in maintaining proper folding of a full-length ZnT8 protein outside its native membrane environment. Through a combined bioengineering and nanotechnology approach, we have developed a proteoliposome-based full-length ZnT8 self-antigen (full-length ZnT8 proteoliposomes; PLR-ZnT8) for efficient detection of ZnT8A on a plasmonic gold chip (pGOLD). The protective lipid matrix of proteoliposomes improved the proper folding and structural stability of full-length ZnT8, helping PLR-ZnT8 immobilized on pGOLD (PLR-ZnT8/pGOLD) achieve high-affinity capture of ZnT8A from T1D sera. Our PLR-ZnT8/pGOLD exhibited efficient ZnT8A detection for T1D diagnosis with ~76% sensitivity and ~97% specificity (n = 307), superior to assays based on detergent-solubilized full-length ZnT8 and the C-terminal domain of ZnT8. Multiplexed assays using pGOLD were also developed for simultaneous detection of ZnT8A, islet antigen 2 autoantibody, and glutamic acid decarboxylase autoantibody for diagnosing T1D. |
Persistent Identifier | http://hdl.handle.net/10722/334502 |
ISSN | 2023 Impact Factor: 9.4 2023 SCImago Journal Rankings: 3.737 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wan, Hao | - |
dc.contributor.author | Merriman, Chengfeng | - |
dc.contributor.author | Atkinson, Mark A. | - |
dc.contributor.author | Wasserfall, Clive H. | - |
dc.contributor.author | Mcgrail, Kieran M. | - |
dc.contributor.author | Liang, Yongye | - |
dc.contributor.author | Fu, Dax | - |
dc.contributor.author | Dai, Hongjie | - |
dc.date.accessioned | 2023-10-20T06:48:36Z | - |
dc.date.available | 2023-10-20T06:48:36Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | Proceedings of the National Academy of Sciences of the United States of America, 2017, v. 114, n. 38, p. 10196-10201 | - |
dc.identifier.issn | 0027-8424 | - |
dc.identifier.uri | http://hdl.handle.net/10722/334502 | - |
dc.description.abstract | Identified as a major biomarker for type 1 diabetes (T1D) diagnosis, zinc transporter 8 autoantibody (ZnT8A) has shown promise for staging disease risk and disease diagnosis. However, existing assays for ZnT8 autoantibody (ZnT8A) are limited to detection by soluble domains of ZnT8, owing to difficulties in maintaining proper folding of a full-length ZnT8 protein outside its native membrane environment. Through a combined bioengineering and nanotechnology approach, we have developed a proteoliposome-based full-length ZnT8 self-antigen (full-length ZnT8 proteoliposomes; PLR-ZnT8) for efficient detection of ZnT8A on a plasmonic gold chip (pGOLD). The protective lipid matrix of proteoliposomes improved the proper folding and structural stability of full-length ZnT8, helping PLR-ZnT8 immobilized on pGOLD (PLR-ZnT8/pGOLD) achieve high-affinity capture of ZnT8A from T1D sera. Our PLR-ZnT8/pGOLD exhibited efficient ZnT8A detection for T1D diagnosis with ~76% sensitivity and ~97% specificity (n = 307), superior to assays based on detergent-solubilized full-length ZnT8 and the C-terminal domain of ZnT8. Multiplexed assays using pGOLD were also developed for simultaneous detection of ZnT8A, islet antigen 2 autoantibody, and glutamic acid decarboxylase autoantibody for diagnosing T1D. | - |
dc.language | eng | - |
dc.relation.ispartof | Proceedings of the National Academy of Sciences of the United States of America | - |
dc.subject | Autoantibody | - |
dc.subject | Full-length ZnT8 | - |
dc.subject | Plasmonic | - |
dc.subject | Proteoliposome | - |
dc.subject | Type 1 diabetes | - |
dc.title | Proteoliposome-based full-length ZnT8 self-antigen for type 1 diabetes diagnosis on a plasmonic platform | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1073/pnas.1711169114 | - |
dc.identifier.pmid | 28874568 | - |
dc.identifier.scopus | eid_2-s2.0-85029551622 | - |
dc.identifier.volume | 114 | - |
dc.identifier.issue | 38 | - |
dc.identifier.spage | 10196 | - |
dc.identifier.epage | 10201 | - |
dc.identifier.eissn | 1091-6490 | - |
dc.identifier.isi | WOS:000411157100071 | - |